US-funded research into the health of people abroad has large health and economic benefits for Americans.
Articles on River blindness
Displaying all articles
Public health campaigns had made significant strides toward eradicating diseases like elephantitis and river blindness. But this progress has since unraveled with the second Trump administration.
River blindness and the black flies that cause it torment millions in west Africa. The “slash and clear” method is an effective way to eliminate them at source.
Neglected tropical diseases of the skin are stigmatised, and may affect an individual’s quality of life
The motivations for Carter’s interest in Africa are deeply personal. His record should remind all democrats, including those in Africa, to hold leaders accountable to high ethical standards.
While Nigeria has made progress in controlling some neglected tropical diseases, it should do more as it carries a heavy burden of these diseases.
Ivermectin has been a lifesaving drug for people with parasitic infections like river blindness and strongyloidiasis. But taking it for COVID-19 may result in the opposite effect.
A cure for many tropical diseases was discovered 30 years ago this month. The drug is donated by its manufacturer. Why are we still dealing with neglected tropical diseases?
Although there have been global efforts to eliminate parasites, some parasites and vectors will have survived attack because they have evolved resistance.
The drug that led to two scientists wining the Nobel Prize for Physiology or medicine has made a significant difference for those suffering from elephantiasis and river blindness.
Many tropical diseases such as malaria, Chagas disease and dengue are transmitted to humans via mosquitoes and other carriers known as vectors. These vector-borne diseases continue to have a major impact…
Onchocerciasis, or river blindness as it’s more commonly known, is a major public health problem in the wet tropics, and especially in tropical Africa. This eye and skin disease is caused by a filaria…
Top contributors
-
Lecturer in Public Health, University of Liverpool
-
Ph.D. Candidate in Microbiology, Harvard University
-
President of the Royal Statistical Society and Professor of Biostatistics, Epidemiology and Population Health, Lancaster University
-
Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine
-
Senior Lecturer in Parasite Epidemiology, School of Natural and Environmental Sciences, Newcastle University
-
Senior Research Fellow in Global Health, University of Southampton
-
Honorary Professor of International Relations, University of the Witwatersrand
-
Professor of Dermatology , University of Lome
-
Associate Professor of Pharmacy, University of Connecticut
-
Professor of Dermatology, University of Lome
-
Research project Manager, PhD candidate at University of Antwerp, University of Antwerp
-
Professor of Parasitology and Epidemiology, Federal University of Agriculture, Abeokuta
-
FAR-LeaF Fellow, University of Pretoria
-
Associate Professor of Medicine, Washington University in St. Louis
-
Instructor in Pediatrics and Infectious Diseases, Washington University in St. Louis